Presented at Digital Pathology & AI Congress Europe 2025.
Quantitative Digital Pathology workflows are playing an increasingly important role across Pharma R&D, improving data quality, supporting remote collaboration, and enabling the application of AI-powered image analysis. As study workloads scale, standardised QC, interoperability, and structured data handling are becoming essential to maintain reliable outcomes.
OracleBio presented how AI tools and Python scripting can strengthen internal Quantitative Digital Pathology pipelines, reducing manual effort, improving QC steps, and supporting more consistent execution across complex studies.
What you’ll learn:
- Incoming images undergo virus scanning, file integrity checks, and metadata validation before analysis to ensure accuracy at the start of the workflow.
- Brightfield and multiplex staining issues are flagged using HALO Stain QC and a Python-based QC tool, supporting interoperability across image analysis platforms.
- A browser-based data curation tool enables scientists to edit fields, apply formulas, and perform QC checks at scale, reducing spreadsheet overhead and improving data consistency.
Click the thumbnail above to download the full poster and see how OracleBio is applying digital pathology and AI-supported workflows to improve the efficiency of R&D studies.
Stay up to date with OracleBio
Sign up to our mailing list to stay informed about news, webinars, events and more
You might also like these Posters:
High ICOS/FOXP3 Tregs Content in the Tumor Microenvironment is Associated with Poorer Survival in Patients with Hepatocellular Carcinoma
OracleBio data quantifying ICOS and FoxP3 dual IHC in clinical HCC samples is presented on a collaborative poster at the AACR 2020 Virtual Annual Meeting. The poster, produced in collaboration with Kymab and the National Taiwan University Hospital, explores the...
Applying deep learning classification for tumor identification across immunohistochemical markers on serial sections to eliminate the need for image co-registration
OracleBio presented a poster at the Society for Immunotherapy of Cancer Annual Meeting 2019 on the 6th – 10th November. The poster is entitled ‘Applying deep learning classification for tumor identification across immunohistochemical markers on serial sections to...
Characterization of Anti-CTLA-4 Effects on Tumor Growth and Immune Microenvironment in a Syngeneic CT26.WT Colon Carcinoma Mouse Model
In collaboration with Pharmatest, OracleBio presented a poster at the AACR Annual Meeting 2019, which took place from the 29th of March to the 3rd of April 2019. The poster is entitled ‘Characterization of Anti-CTLA-4 Effects on Tumor Growth and Immune...



